HUTCHMED (China) Limited (HCM) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 1 recommend selling.
The analyst consensus price target for HCM is $17.50, representing a +15.1% upside from the current price of $15.21. Price targets range from a low of $17.50 to a high of $17.50.
